Literature DB >> 31577934

Dietary Sugars Alter Hepatic Fatty Acid Oxidation via Transcriptional and Post-translational Modifications of Mitochondrial Proteins.

Samir Softic1, Jesse G Meyer2, Guo-Xiao Wang3, Manoj K Gupta4, Thiago M Batista3, Hans P M M Lauritzen3, Shiho Fujisaka5, Dolors Serra6, Laura Herrero6, Jennifer Willoughby7, Kevin Fitzgerald7, Olga Ilkayeva8, Christopher B Newgard8, Bradford W Gibson2, Birgit Schilling2, David E Cohen9, C Ronald Kahn10.   

Abstract

Dietary sugars, fructose and glucose, promote hepatic de novo lipogenesis and modify the effects of a high-fat diet (HFD) on the development of insulin resistance. Here, we show that fructose and glucose supplementation of an HFD exert divergent effects on hepatic mitochondrial function and fatty acid oxidation. This is mediated via three different nodes of regulation, including differential effects on malonyl-CoA levels, effects on mitochondrial size/protein abundance, and acetylation of mitochondrial proteins. HFD- and HFD plus fructose-fed mice have decreased CTP1a activity, the rate-limiting enzyme of fatty acid oxidation, whereas knockdown of fructose metabolism increases CPT1a and its acylcarnitine products. Furthermore, fructose-supplemented HFD leads to increased acetylation of ACADL and CPT1a, which is associated with decreased fat metabolism. In summary, dietary fructose, but not glucose, supplementation of HFD impairs mitochondrial size, function, and protein acetylation, resulting in decreased fatty acid oxidation and development of metabolic dysregulation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acetylation; fatty acid oxidation; fatty liver disease; fructose; glucose; ketohexokinase; mass spectrometry; mitochondria; obesity; sugar

Mesh:

Substances:

Year:  2019        PMID: 31577934      PMCID: PMC7816129          DOI: 10.1016/j.cmet.2019.09.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  64 in total

1.  The first 28 N-terminal amino acid residues of human heart muscle carnitine palmitoyltransferase I are essential for malonyl CoA sensitivity and high-affinity binding.

Authors:  J Shi; H Zhu; D N Arvidson; G Woldegiorgis
Journal:  Biochemistry       Date:  2000-02-01       Impact factor: 3.162

Review 2.  Acetylation and deacetylation of non-histone proteins.

Authors:  Michele A Glozak; Nilanjan Sengupta; Xiaohong Zhang; Edward Seto
Journal:  Gene       Date:  2005-11-11       Impact factor: 3.688

3.  Monitoring protein expression in whole-cell extracts by targeted label- and standard-free LC-MS/MS.

Authors:  Katharina Bluemlein; Markus Ralser
Journal:  Nat Protoc       Date:  2011-05-26       Impact factor: 13.491

4.  The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase.

Authors:  G van den Berghe; M Bronfman; R Vanneste; H G Hers
Journal:  Biochem J       Date:  1977-03-15       Impact factor: 3.857

Review 5.  Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.

Authors:  Samir Softic; David E Cohen; C Ronald Kahn
Journal:  Dig Dis Sci       Date:  2016-02-08       Impact factor: 3.199

6.  ChREBP regulates fructose-induced glucose production independently of insulin signaling.

Authors:  Mi-Sung Kim; Sarah A Krawczyk; Ludivine Doridot; Alan J Fowler; Jennifer X Wang; Sunia A Trauger; Hye-Lim Noh; Hee Joon Kang; John K Meissen; Matthew Blatnik; Jason K Kim; Michelle Lai; Mark A Herman
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

7.  An integrated catalog of reference genes in the human gut microbiome.

Authors:  Junhua Li; Huijue Jia; Xianghang Cai; Huanzi Zhong; Qiang Feng; Shinichi Sunagawa; Manimozhiyan Arumugam; Jens Roat Kultima; Edi Prifti; Trine Nielsen; Agnieszka Sierakowska Juncker; Chaysavanh Manichanh; Bing Chen; Wenwei Zhang; Florence Levenez; Juan Wang; Xun Xu; Liang Xiao; Suisha Liang; Dongya Zhang; Zhaoxi Zhang; Weineng Chen; Hailong Zhao; Jumana Yousuf Al-Aama; Sherif Edris; Huanming Yang; Jian Wang; Torben Hansen; Henrik Bjørn Nielsen; Søren Brunak; Karsten Kristiansen; Francisco Guarner; Oluf Pedersen; Joel Doré; S Dusko Ehrlich; Peer Bork; Jun Wang
Journal:  Nat Biotechnol       Date:  2014-07-06       Impact factor: 54.908

8.  Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

Authors:  Sabine Thuy; Ruth Ladurner; Valentina Volynets; Silvia Wagner; Stefan Strahl; Alfred Königsrainer; Klaus-Peter Maier; Stephan C Bischoff; Ina Bergheim
Journal:  J Nutr       Date:  2008-08       Impact factor: 4.798

9.  Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women.

Authors:  C L Cox; K L Stanhope; J M Schwarz; J L Graham; B Hatcher; S C Griffen; A A Bremer; L Berglund; J P McGahan; P J Havel; N L Keim
Journal:  Eur J Clin Nutr       Date:  2011-09-28       Impact factor: 4.016

10.  Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export.

Authors:  Phillip J White; Amanda L Lapworth; Jie An; Liping Wang; Robert W McGarrah; Robert D Stevens; Olga Ilkayeva; Tabitha George; Michael J Muehlbauer; James R Bain; Jeff K Trimmer; M Julia Brosnan; Timothy P Rolph; Christopher B Newgard
Journal:  Mol Metab       Date:  2016-04-22       Impact factor: 7.422

View more
  47 in total

1.  Deletion of Fructokinase in the Liver or in the Intestine Reveals Differential Effects on Sugar-Induced Metabolic Dysfunction.

Authors:  Ana Andres-Hernando; David J Orlicky; Masanari Kuwabara; Takuji Ishimoto; Takahiko Nakagawa; Richard J Johnson; Miguel A Lanaspa
Journal:  Cell Metab       Date:  2020-06-04       Impact factor: 27.287

Review 2.  Fructose and hepatic insulin resistance.

Authors:  Samir Softic; Kimber L Stanhope; Jeremie Boucher; Senad Divanovic; Miguel A Lanaspa; Richard J Johnson; C Ronald Kahn
Journal:  Crit Rev Clin Lab Sci       Date:  2020-01-14       Impact factor: 6.250

3.  Dedicator of Cytokinesis 2 (DOCK2) Deficiency Attenuates Lung Injury Associated with Chronic High-Fat and High-Fructose Diet-Induced Obesity.

Authors:  Guoqing Qian; Oluwaseun Adeyanju; Christudas Sunil; Steven K Huang; Shi-You Chen; Torry A Tucker; Steven Idell; Xia Guo
Journal:  Am J Pathol       Date:  2021-11-10       Impact factor: 4.307

Review 4.  Molecular aspects of fructose metabolism and metabolic disease.

Authors:  Mark A Herman; Morris J Birnbaum
Journal:  Cell Metab       Date:  2021-10-06       Impact factor: 27.287

5.  Loss of Glp2r signaling activates hepatic stellate cells and exacerbates diet-induced steatohepatitis in mice.

Authors:  Shai Fuchs; Bernardo Yusta; Laurie L Baggio; Elodie M Varin; Dianne Matthews; Daniel J Drucker
Journal:  JCI Insight       Date:  2020-04-23

6.  Hat1-Dependent Lysine Acetylation Targets Diverse Cellular Functions.

Authors:  Paula A Agudelo Garcia; Prabakaran Nagarajan; Mark R Parthun
Journal:  J Proteome Res       Date:  2020-03-04       Impact factor: 4.466

Review 7.  Are fat and sugar just as detrimental in old age?

Authors:  Ana P Valencia; Nitin Nagaraj; Deena H Osman; Peter S Rabinovitch; David J Marcinek
Journal:  Geroscience       Date:  2021-06-08       Impact factor: 7.713

Review 8.  Strategies to Understand the Weight-Reduced State: Genetics and Brain Imaging.

Authors:  Ruth J F Loos; Charles Burant; Ellen A Schur
Journal:  Obesity (Silver Spring)       Date:  2021-04       Impact factor: 5.002

9.  Fructose and Uric Acid as Drivers of a Hyperactive Foraging Response: A Clue to Behavioral Disorders Associated with Impulsivity or Mania?

Authors:  Richard J Johnson; William L Wilson; Sondra T Bland; Miguel A Lanaspa
Journal:  Evol Hum Behav       Date:  2020-10-01       Impact factor: 4.178

10.  High-fat diet activates a PPAR-δ program to enhance intestinal stem cell function.

Authors:  Semir Beyaz; Miyeko D Mana; Ömer H Yilmaz
Journal:  Cell Stem Cell       Date:  2021-04-01       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.